- Home
- GNLX vs NEN Comparison
GNLX vs NEN Comparison
Compare GNLX & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
NEN
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
Company Overview
Basic Information| Metric | GNLX | NEN |
|---|---|---|
| Founded | 2001 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 227.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNLX | NEN |
|---|---|---|
| Price | $2.92 | $65.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 355.3K | 1.3K |
| Earning Date | 11-05-2025 | 03-12-2026 |
| Dividend Yield | N/A | ★ 7.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.33 |
| Revenue | N/A | ★ $87,362,592.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.54 |
| Revenue Growth | N/A | ★ 7.63 |
| 52 Week Low | $1.99 | $62.10 |
| 52 Week High | $8.54 | $84.00 |
Technical Indicators
Market Signals| Indicator | GNLX | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 47.46 |
| Support Level | $2.52 | $62.41 |
| Resistance Level | $2.80 | $65.30 |
| Average True Range (ATR) | 0.34 | 0.65 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 16.17 | 64.61 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.